参考文献/References:
[1] Bagheri B,Maurer AH,Cone L,et al.Characterization of the normal adrenal gland with 18F-FIDG PET/CT.J Nucl Med,2004,45(8):1340-1343.
[2] Blake MA,S1attery JM,Kalra MK,et al.Adrenal lesions:characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience.Radiology,2006,238(3):970-977.
[3] Okada M,Shimono T,Komeya Y,et al.Adrenal masses:the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.Ann Nucl Med,2009,23(4):349-354.
[4] Tessonnier L,Sebag F,Palazzo FF,et al.Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?.Eur J Nucl Med Mol Imaging,2008,35(11):2018-2025.
[5] Jana S,Zhang T,Milstein DM,et al.FDG-PET and CT characterization of adrenal lesions in cancer patients.Eur J Nucl Med Mol Imaging,2006,33(1):29-35.
[6] Metser U,Miller E,Lerman H,et al.18F-FDG PET/CT in the evaluation of adrenal masses.J Nucl Med,2006,47(1):32-37.
[7] Elaini AB,Shetty SK,Chapman VM,et al.Improved detection and characterization of adrenal disease with PET-CT.Radiographics,2007,27(3):755-767.
[8] Chong S,Lee KS,Kim HY,et al.Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients:diagnostic efficacy and interpretation pitfalls.Radiographics,2006,26(6):1811-1824.
[9] Rao SK,Caride VJ,Ponn R,et al.F-18 fluorodeoxyglucose positron emission tomography-positive benign adrenal cortical adenoma:imaging features and pathologic correlation.Clin Nucl Med,2004,29(5):300-302.
[10] Basu S,Nair N.18F-FDG uptake in bilateral adrenal hyperplasia causing Cushing’s syndrome.Eur J Nucl Mol Med Imaging,2005,32(3):384.
[11] Vikram R,Yeung HD,Macaginlac HA,et al.Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer.AJR Am J Roentgenol,2008,191(5):1545-1551.
[12] Narang V,Sinha T,Sandhu AS,et al.Clinically inapparent bilateral adrenal masses due to histoplasmosis.Eur Urol,2009,55(2):518-521.
[13] Kim DJ,Chung JJ,Ryu YH,et al.Adrenocortical oncocytoma displaying intense activity on 18F-FDG-PET:a case report and a literature review.Ann Nucl Med,2008,22(9):821-824.
[14] Hennings J,Lindhe O,Bergström M,et al.[11C] metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.J Clin Endocrinol Metab,2006,91(4):1410-1414.
[15] Gross MD,Avram A,Fig LM,et al.Contemporary adrenal acintigraphy.EurJ Nucl Med Mol Imaging,2007,34(4):547-557.
[16] Hennings J,Hellman P,Ahlström H,et al.Computed tomography,magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.Eur J Radiol,2009,69(2):314-323.
[17] Gross MD,Rubello D.Something old,something new,PET in adrenal imaging.Eur J Nucl Med Mol Imaging,2008,35(7):1233-1235.
[18] Wadsak W,Mitterhauser M,Rendl G,et al.[18F] FETO for adrenocortical PET imaging:a pilot study in healthy volunteers.Eur J Nucl Med Mol Imaging,2006,33(6):669-672.
[19] Yamaga LY,Thom AF,Wagner J,et al.The effect of catecholamines on the glucose uptake in brown adipose tissue demonstrated by (18)F-FDG PET/CT in a patient with adrenal pheochromocytoma.Eur J Nucl Med Mol Imaging,2008,35(2):446-447.
[20] Mann GN,Link JM,Pham P,et al.[11C] metahydroxyephedrine and[18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.Ann Surg Oncol,2006,13(2):187-197.
[21] Brink I,Hoegerle S,Klisch J,et al.Imaging of pheochromocytoma and paraganglioma.Fam Cancer,2005,4(1):61-68.
[22] Imani F,Agopian VG,Auerbach MS,et al.18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.J Nucl Med,2009,50(4):513-519.
[23] Taǐeb D,Tessonnier L,Sebag F,et al.The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.Clin Endocrinol(Oxf),2008,69(4):580-586.
[24] Kaji P,Carrasquillo JA,Linehan WM,et al.The role of 6-[18F] fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with yon Hippel-Lindau syndrome.Eur J Endocrinol,2007,156(4):483-487.
[25] Timmers HJ,Carrasquillo JA,Whatley M,et al.Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6-18Ffluorodopamine PET.J Nucl Med,2007,48(12):1940-1944.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[8]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[9]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[10]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[11]罗家伦,徐慧琴,何延辉,等.18F-FDG PET-CT在肾上腺转移癌诊断中的价值及其诊断标准探讨[J].国际放射医学核医学杂志,2012,36(2):87.[doi:10.3760/cma.j.issn.1673-4114.2012.02.007]
LUO Jia-lun,XU Hui-qin,HE Yan-hui,et al.Diagnostic value and diagnostic criteria of 18F-FDG PET-CT in adrenal metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):87.[doi:10.3760/cma.j.issn.1673-4114.2012.02.007]